Processa Pharmaceuticals, Inc. - Common Stock - Nakit Akışı (NASDAQ:PCSA) | MetaTrader

Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

İşletme faaliyetlerinden elde edilen nakit -3.14 M-8.72 M-9.61 M-8.06 M-11.25 M-11.39 M -12.25 M Yatırım faaliyetlerinden elde edilen nakit -8.7 M——-2 776-3 244-850 K — Finansman faaliyetlerinden elde edilen nakit 17.87 M9.8 M-388.84 K6.27 M7.73 M16.58 M 12.39 M Serbest nakit akışı -3.14 M-8.72 M-9.61 M-8.06 M-11.25 M-12.24 M -12.75 M

Haberler

Why Penguin Solutions Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - AAR (NYSE:AIR), Alpha Modus Holdings (NASDAQ:AMOD)

Processa Pharmaceuticals completes enrollment for NGC-Cap breast cancer study

PCSA Stock Soars on Upbeat Clinical Update From Breast Cancer Study

Why MillerKnoll Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Akanda (NASDAQ:AKAN), Actelis Networks (NASDAQ:ASNS)

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.47%

Here’s Why Penny Stock Processa Pharmaceuticals (PCSA) Is Exploding Today - TipRanks.com

Processa Pharmaceuticals hisseleri, kanser ilacının umut verici sonuçlar göstermesiyle yükseldi

Processa Pharmaceuticals stock soars after cancer drug shows promising results

Processa, kanser tedavisi için olumlu ön veriler açıkladı

Processa reports positive preliminary data for cancer therapy

Processa Pharmaceuticals announces 1-for-25 reverse stock split effective this week

Processa to present FSGS treatment study at ASN Kidney Week 2025